These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 19760607

  • 1. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP, Xue YQ, Zhou JW, Li AP, Wu YF, Pan JL, Wang Y, Zhang J.
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [Abstract] [Full Text] [Related]

  • 2. Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22).
    Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M.
    Genes Chromosomes Cancer; 2005 Nov; 44(3):265-70. PubMed ID: 16015645
    [Abstract] [Full Text] [Related]

  • 3. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T, Hasan SK, Montefusco E, Curzi P, Mays AN, Chessa L, Ferrari A, Conte E, Noguera NI, Lavorgna S, Ammatuna E, Divona M, Bovetti K, Amadori S, Grimwade D, Lo-Coco F.
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [Abstract] [Full Text] [Related]

  • 4. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE.
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [Abstract] [Full Text] [Related]

  • 5. PRDX4, a member of the peroxiredoxin family, is fused to AML1 (RUNX1) in an acute myeloid leukemia patient with a t(X;21)(p22;q22).
    Zhang Y, Emmanuel N, Kamboj G, Chen J, Shurafa M, Van Dyke DL, Wiktor A, Rowley JD.
    Genes Chromosomes Cancer; 2004 Aug; 40(4):365-70. PubMed ID: 15188461
    [Abstract] [Full Text] [Related]

  • 6. RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.
    De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Morel F, Férec C, De Braekeleer M.
    Cancer Genet Cytogenet; 2008 Aug; 185(1):47-50. PubMed ID: 18656694
    [Abstract] [Full Text] [Related]

  • 7. A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22).
    Abe A, Katsumi A, Kobayashi M, Okamoto A, Tokuda M, Kanie T, Yamamoto Y, Naoe T, Emi N.
    Cancer Genet; 2012 Nov; 205(11):608-11. PubMed ID: 23102734
    [Abstract] [Full Text] [Related]

  • 8. A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia.
    Mikhail FM, Coignet L, Hatem N, Mourad ZI, Farawela HM, El Kaffash DM, Farahat N, Nucifora G.
    Genes Chromosomes Cancer; 2004 Feb; 39(2):110-8. PubMed ID: 14695990
    [Abstract] [Full Text] [Related]

  • 9. Identification of novel Runx1 (AML1) translocation partner genes SH3D19, YTHDf2, and ZNF687 in acute myeloid leukemia.
    Nguyen TT, Ma LN, Slovak ML, Bangs CD, Cherry AM, Arber DA.
    Genes Chromosomes Cancer; 2006 Oct; 45(10):918-32. PubMed ID: 16858696
    [Abstract] [Full Text] [Related]

  • 10. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS, Choi JR, Yoon SH, Song J, Kim J, Kim SJ, Kwon O, Min YH.
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [Abstract] [Full Text] [Related]

  • 11. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 12. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
    Dai H, Xue Y, Pan J, Wu Y, Wang Y, Shen J, Zhang J.
    Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
    [Abstract] [Full Text] [Related]

  • 13. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
    Ter Elst A, Ma B, Scherpen FJ, de Jonge HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA, de Bont ES.
    Cancer Res; 2011 Apr 01; 71(7):2761-71. PubMed ID: 21447743
    [Abstract] [Full Text] [Related]

  • 14. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
    Schafhausen P, Dierlamm J, Bokemeyer C, Bruemmendorf TH, Bacher U, Zander AR, Schnittger S, Hochhaus A.
    Cancer Genet Cytogenet; 2009 Feb 01; 189(1):63-7. PubMed ID: 19167615
    [No Abstract] [Full Text] [Related]

  • 15. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
    Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW.
    Nat Med; 2002 Jul 01; 8(7):743-50. PubMed ID: 12091906
    [Abstract] [Full Text] [Related]

  • 16. CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22).
    Giguère A, Hébert J.
    Cancer Genet Cytogenet; 2010 Oct 15; 202(2):94-100. PubMed ID: 20875871
    [Abstract] [Full Text] [Related]

  • 17. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
    Hsiao HH, Sashida G, Kodama A, Fukutake K, Ohyashiki K.
    Cancer Genet Cytogenet; 2005 May 15; 159(1):96-7. PubMed ID: 15860366
    [No Abstract] [Full Text] [Related]

  • 18. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S, Hoogeveen AT, Liang P, Stanciu C, van der Spek P, Sacchi N.
    BMC Genomics; 2007 Feb 01; 8():38. PubMed ID: 17266773
    [Abstract] [Full Text] [Related]

  • 19. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y, Harada H.
    J Cell Physiol; 2009 Jul 01; 220(1):16-20. PubMed ID: 19334039
    [Abstract] [Full Text] [Related]

  • 20. Cryptic and partial deletions of PRDM16 and RUNX1 without t(1;21)(p36;q22) and/or RUNX1-PRDM16 fusion in a case of progressive chronic myeloid leukemia: a complex chromosomal rearrangement of underestimated frequency in disease progression?
    Deluche L, Joha S, Corm S, Daudignon A, Geffroy S, Quief S, Villenet C, Kerckaert JP, Laï JL, Preudhomme C, Roche-Lestienne C.
    Genes Chromosomes Cancer; 2008 Dec 01; 47(12):1110-7. PubMed ID: 18767145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.